The University of Chicago Header Logo

Connection

John Edward A. Blair to Aged

Back to Details
This is a "connection" page, showing publications John Edward A. Blair has written about Aged.
John Edward A. Blair
Connection Strength
0.608
Aged
  1. Use of Prospective Radiobrachial Angiography in Transradial Cardiac Catheterization and Intervention. Cardiovasc Revasc Med. 2020 06; 21(6):797-803.
    View in: PubMed
    Score: 0.051
  2. Coronary Microvascular Dysfunction and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. J Card Fail. 2019 10; 25(10):843-845.
    View in: PubMed
    Score: 0.050
  3. Broken arrow: Successful retrieval of a dislodged coronary orbital atherectomy microtip. Catheter Cardiovasc Interv. 2018 09 01; 92(3):511-514.
    View in: PubMed
    Score: 0.047
  4. Electronic cardiac arrest triage score best predicts mortality after intervention in patients with massive and submassive pulmonary embolism. Catheter Cardiovasc Interv. 2018 08 01; 92(2):366-371.
    View in: PubMed
    Score: 0.046
  5. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018 05 01; 314(5):H1033-H1042.
    View in: PubMed
    Score: 0.045
  6. Transcatheter Therapy for a Large Mobile Right Atrial Thrombus and Massive Pulmonary Embolism. J Invasive Cardiol. 2016 May; 28(5):E49-51.
    View in: PubMed
    Score: 0.040
  7. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011 Oct; 32(20):2563-72.
    View in: PubMed
    Score: 0.029
  8. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009 Jul; 30(13):1666-73.
    View in: PubMed
    Score: 0.025
  9. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11; 52(20):1640-8.
    View in: PubMed
    Score: 0.024
  10. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther. 2008 May-Jun; 15(3):231-40.
    View in: PubMed
    Score: 0.023
  11. Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome. Acute Card Care. 2007; 9(4):207-13.
    View in: PubMed
    Score: 0.021
  12. Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK). J Card Fail. 2024 Jul; 30(7):952-957.
    View in: PubMed
    Score: 0.017
  13. Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease. Vascular. 2021 Jun; 29(3):355-362.
    View in: PubMed
    Score: 0.014
  14. Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2019 Dec 01; 94(7):1028-1033.
    View in: PubMed
    Score: 0.013
  15. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease. Exp Physiol. 2019 09; 104(9):1343-1352.
    View in: PubMed
    Score: 0.013
  16. Percutaneous Transapical Left Ventricular Access to Treat Paravalvular Leak and Ventricular Septal Defect. J Invasive Cardiol. 2019 Sep; 31(9):247-252.
    View in: PubMed
    Score: 0.012
  17. Percutaneous Coronary Intervention following Placement of Sutureless Aortic Bioprostheses. Innovations (Phila). 2019 Apr; 14(2):177-182.
    View in: PubMed
    Score: 0.012
  18. Cost-utility of extracorporeal cardiopulmonary resuscitation in patients with cardiac arrest. Resuscitation. 2019 03; 136:126-130.
    View in: PubMed
    Score: 0.012
  19. Peak left atrial strain as a single measure for the non-invasive assessment of left ventricular filling pressures. Int J Cardiovasc Imaging. 2019 Jan; 35(1):23-32.
    View in: PubMed
    Score: 0.012
  20. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation. Int J Cardiovasc Imaging. 2018 Oct; 34(10):1607-1617.
    View in: PubMed
    Score: 0.012
  21. Mechanical chest compressions improve rate of return of spontaneous circulation and allow for initiation of percutaneous circulatory support during cardiac arrest in the cardiac catheterization laboratory. Resuscitation. 2017 06; 115:56-60.
    View in: PubMed
    Score: 0.011
  22. Catheter-Directed Fibrinolysis of Submassive Pulmonary Embolism After IVC Filter Migration to Renal Veins. J Invasive Cardiol. 2017 Jan; 29(1):E8-E9.
    View in: PubMed
    Score: 0.010
  23. Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation. Catheter Cardiovasc Interv. 2015 Apr; 85(5):828-31.
    View in: PubMed
    Score: 0.009
  24. Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment. J Cardiovasc Med (Hagerstown). 2012 Jul; 13(7):415-22.
    View in: PubMed
    Score: 0.008
  25. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010 May; 159(5):841-849.e1.
    View in: PubMed
    Score: 0.007
  26. Use of hand carried ultrasound, B-type natriuretic peptide, and clinical assessment in identifying abnormal left ventricular filling pressures in patients referred for right heart catheterization. J Card Fail. 2010 Jan; 16(1):69-75.
    View in: PubMed
    Score: 0.006
  27. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J. 2009 Sep; 158(3):437-43.
    View in: PubMed
    Score: 0.006
  28. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009 Sep; 30(18):2233-40.
    View in: PubMed
    Score: 0.006
  29. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009 Jun; 157(6):1035-41.
    View in: PubMed
    Score: 0.006
  30. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. JACC Cardiovasc Imaging. 2008 Sep; 1(5):595-601.
    View in: PubMed
    Score: 0.006
  31. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008 Jun 10; 51(23):2276-85.
    View in: PubMed
    Score: 0.006
  32. Radial artery pulse pressure variation correlates with brachial artery peak velocity variation in ventilated subjects when measured by internal medicine residents using hand-carried ultrasound devices. Chest. 2007 May; 131(5):1301-7.
    View in: PubMed
    Score: 0.005
  33. A comparison by medicine residents of physical examination versus hand-carried ultrasound for estimation of right atrial pressure. Am J Cardiol. 2007 Jun 01; 99(11):1614-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.